Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Acta Medica Philippina|July 5, 2024
Effect of Terpenes on the Enhancement of Skin Permeation of Lipophilic Drugs: A Systematic ReviewLlani D Longgos, Erikka B Pequiro, Lord Sam B Liston, et al.
Acta Medica Philippina|March 28, 2025
Exploring the Knowledge, Attitude, and Practices of Community Pharmacists in Eastern Visayas towards Readiness to Provide Information Service on Complementary and Alternative Medicine (CAM) ProductsArchie M Cabachete, Judah Israel O Lescano, Lorraine V Tagle, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2024
Oxytocin receptor function regulates neural signatures of pair bonding and fidelity in the nucleus accumbensKimberly L P Long, Nerissa E G Hoglen, Alex J Keip, et al.
Eye (London, England)|March 26, 2011
Changes in retinal nerve fibre layer, optic nerve head morphology, and visual field after acute primary angle closureC C A Sng, J S L See, C S Ngo, et al.
Journal of Glaucoma|September 17, 2008
Changes in angle configuration after phacoemulsification measured by anterior segment optical coherence tomographyWinifred P Nolan, Jovina L See, Tin Aung, et al.
British Journal of Haematology|March 29, 2023
Oral azacitidine modulates the bone marrow microenvironment in patients with acute myeloid leukaemia in remission: A subanalysis from the QUAZAR AML-001 trialDaniel L Menezes, Wendy L See, Alberto Risueño, et al.
Leukemia Research|April 2, 2024
Somatic gene mutation patterns and burden influence outcomes with enasidenib in relapsed/refractory IDH2-mutated AMLAlberto Risueño, Wendy L See, Iryna Bluemmert, et al.
British Journal of Haematology|November 12, 2023
Survival outcomes in patients with acute myeloid leukaemia who received subsequent therapy for relapse in QUAZAR AML-001Farhad Ravandi, Hartmut Döhner, Andrew H Wei, et al.
Melanoma Research|September 22, 2007
Dendritic cell immunotherapy for stage IV melanomaMichael G E O'Rourke, Maree K Johnson, Catherine M Lanagan, et al.
Immunology and Cell Biology|May 10, 2006
Immunological characteristics correlating with clinical response to immunotherapy in patients with advanced metastatic melanomaJulia A Marshall, Trevor H Forster, David M Purdie, et al.
Pageof 6